Blood Cancer Institute Directors & Members
Working in a highly collaborative manner across Montefiore Einstein Comprehensive Cancer Center, global leaders in blood cancer research and care are driving advances in better understanding, preventing, and treating MDS, AML, and myriad other blood cancers. Much of the power of the Blood Cancer Institute derives from the multidisciplinary perspectives, insights, and tools that the members provide.
Blood Cancer Institute Directors
Under the leadership of Marina Konopleva, MD, PhD, Ulrich Steidl, MD, PhD, and Amit Verma, MD, the Blood Cancer Institute is making great strides in expanding treatment options for people with blood cancers.
Marina Konopleva, MD
Ulrich G. Steidl, M.D., Ph.D.
Amit K. Verma, MD
Blood Cancer Institute Assistant Directors
BCI has appointed four Associate Directors to help shape the work and future BCI efforts in the area of basic and translational science. They will assist BCI leadership in fostering research collaborations, mentorship of junior faculty, educational activities, funding initiatives, and translation into novel clinical trials for our patients.
Kira Gritsman, MD, PhD
Aditi Shastri, MD
Britta Will, Ph.D.
Blood Cancer Institute Members
The more than 20 members of the Blood Cancer Institute help shape and drive basic and translational research in blood cancers.
Dennis L. Cooper, MD
Keisuke Ito, M.D., Ph.D.
Nishi Shah, MD, MBBS
